Trellus Health plc (TRLS) ORD GBP0.0006
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Trellus Health plc is a United Kingdom-based health services company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Company’s Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevate’s personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Company’s wholly owned subsidiary is Trellus Health Inc.
Contact details
Important dates
General stock information
- EPIC:
- TRLS
- ISIN:
- GB00BNNFM402
- Market cap:
- £1.41 million
- Shares in issue:
- 161.51 million
- Sector:
- No specific Industry
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.